NCT04365478

Brief Summary

Hands and wrist spasticity are a common post stroke complication and often lead to restrictions in daily living activities. Spasticity causes changes in muscle composition such as accumulation of collagenous connective tissue and progressive loss of skeletal muscle fibres and these changes start almost immediately after a vascular event. Radial Shock Wave Therapy (rSWT) is a valid alternative rehabilitating tool in managing chronic spasticity but no study has so far investigated the effect in a recently onset hemiparesis. The aim of this study is to evaluate the efficacy of an early radial shock wave therapy in improving spasticity of the upper limb in patients with a recent onset stroke. The secondary outcome is to investigate the improvement of upper limb motor functionality, passive range of motion and joint pain and to determine if it can lead to a better performance in daily living activities. This study is a randomized controlled trial double arm single blind. The investigators plan to enrol 40 hemiplegic patients with sub-acute stroke and randomly assign them to an experimental or control group. The experimental group (EG) will perform one radial shock wave therapy session a week for 8 weeks administered during the daily morning 40 minutes of conventional rehabilitation treatment. The control group (CG) 40-minutes of conventional rehabilitation treatment for 5 days per week in the morning for 8 weeks. All patients performed in the afternoon a second daily session of 40 minutes of conventional rehabilitation therapy 5 days per week. The Modified Ashworth Scale (MAS), Fugl-Meyer Assessment Upper Extremity (FMA-UE) (with motricity, Passive Range of Motion (PROM) and pain sub-scores of upper extremity part of the scale), Modified Barthel Index and Visual Analogue Scale (VAS) for patient's benefit perceived, will be evaluated before and a week after the last intervention. MAS will be administered once a week, before rSWT treatment. The investigators plan to have a 1 month follow up during which every outcome measure will be administered. The investigators hypothesize that radial shock waves therapy, started early and associated with traditional physiotherapy, may be more effective in promoting the reduction of spasticity and pain of the upper limb, improve its functionality and therefore a reduction in disability, compared to conventional rehabilitation treatment. A reduction in the use of analgesic and muscle relaxants drugs is also conceivable

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 28, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

May 2, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2021

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 27, 2021

Completed
Last Updated

April 1, 2022

Status Verified

March 1, 2022

Enrollment Period

1.4 years

First QC Date

April 20, 2020

Last Update Submit

March 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Modified Ashworth Scale at 9 weeks and at 13 weeks

    A 6-point scale grading the resistance of a relaxed limb to rapid passive stretch

    baseline the first rSWT treatment, at 9 weeks (1 week after the last treatment) and at 13 weeks (follow up at 4 weeks after the last treatment)

Secondary Outcomes (3)

  • Change from baseline FUGL-MEYER ASSESSMENT UPPER EXTREMITY (FMA-UE) at 9 weeks and at 13 weeks

    baseline the first rSWT treatment, at 9 weeks (1 week after the last treatment) and at 13 weeks (follow up at 4 weeks after the last treatment)

  • Change from baseline Barthel Index at 9 weeks and at 13 weeks

    baseline the first rSWT treatment, at 9 weeks (1 week after the last treatment) and at 13 weeks (follow up at 4 weeks after the last treatment)

  • visual analogue scale (VAS)

    at 9 weeks (at the end of the last rESWT treatment)

Study Arms (2)

rSWT group

EXPERIMENTAL

Radial Extracorporeal Shock Wave Therapy on spastic muscles of upper limb

Procedure: Radial Extracorporeal Shock Wave Therapy

Control group

ACTIVE COMPARATOR

conventional physiotherapy

Procedure: Conventional physiotherapy

Interventions

rSWT group: One radial shock wave therapy session a week for 8 weeks (parameters: 1.5 bar, 10 Hz, 2000 shots for each muscle group treated) administered daily during the morning for 40 minutes of conventional rehabilitation treatment.

rSWT group

Control group: 40-minutes of conventional rehabilitation treatment 5 days per week in the morning (strength exercise, trunk control exercise, stretching exercise, occupational therapy, and neurodevelopmental facilitation techniques) for 8 weeks

Control group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of hemiparesis after an ischemic or hemorrhagic stroke
  • Onset of spasticity within 3 months from acute stroke
  • First-stroke survivors with confirmed brain lesions by tomography or magnetic resonance imaging
  • Adults (age between 18 and 80 years)
  • Post-stroke upper limb spasticity ranging 1-4 according to the Modified Ashworth Scale

You may not qualify if:

  • No treatment of the limb spasticity with botulinum toxin, phenol, alcohol, or surgery in the last 6 months
  • Presence of an unstable medical condition
  • Contraindications to shock waves treatment (pregnancy, cancer, coagulopathies, pacemakers, skin pathologies)
  • Global aphasia
  • All subjects who scored above 25 on the Mini-Mental State Examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stefano Brunelli

Roma, 00179, Italy

Location

Related Publications (3)

  • Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, von Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004 Jan;35(1):134-9. doi: 10.1161/01.STR.0000105386.05173.5E. Epub 2003 Dec 18.

    PMID: 14684785BACKGROUND
  • Lee SS, Spear S, Rymer WZ. Quantifying changes in material properties of stroke-impaired muscle. Clin Biomech (Bristol). 2015 Mar;30(3):269-75. doi: 10.1016/j.clinbiomech.2015.01.004. Epub 2015 Jan 21.

    PMID: 25638688BACKGROUND
  • Manganotti P, Amelio E. Long-term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke. 2005 Sep;36(9):1967-71. doi: 10.1161/01.STR.0000177880.06663.5c. Epub 2005 Aug 18.

    PMID: 16109905BACKGROUND

MeSH Terms

Conditions

Muscle Spasticity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Noemi Gentileschi, MD

    Fondazione Santa Lucia Roma Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD Physiatrist of the Operative Unit 4 for inpatient rehabilitation

Study Record Dates

First Submitted

April 20, 2020

First Posted

April 28, 2020

Study Start

May 2, 2020

Primary Completion

September 20, 2021

Study Completion

September 27, 2021

Last Updated

April 1, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)

Shared Documents
ICF
Time Frame
Beginning 3 months and ending 5 years following article publication.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose; For individual participant data meta-analysis.Proposals should be directed to the personal author's mail address

Locations